These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37758273)

  • 21. Montelukast for prevention and treatment of asthma exacerbations in adults: Systematic review and meta-analysis.
    Zhang HP; Jia CE; Lv Y; Gibson PG; Wang G
    Allergy Asthma Proc; 2014; 35(4):278-87. PubMed ID: 24992547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant medication dispensing among montelukast initiators.
    Zhou EH; Kaplan S; Mosholder A; Moeny D; Ding Y; Wu Y; Iyasu S; Hammad TA
    J Asthma; 2013 Nov; 50(9):990-5. PubMed ID: 23841530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.
    Bisgaard H; Skoner D; Boza ML; Tozzi CA; Newcomb K; Reiss TF; Knorr B; Noonan G
    Pediatr Pulmonol; 2009 Jun; 44(6):568-79. PubMed ID: 19449366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of montelukast sodium combined with fluticasone in the treatment of adult bronchial asthma: A protocol for systematic review and meta-analysis.
    Luo H; Han H; Liu X; Liu Q
    Medicine (Baltimore); 2020 Dec; 99(52):e23453. PubMed ID: 33350727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with montelukast and antidepressive medication-a symmetry analysis.
    Winkel JS; Damkier P; Hallas J; Henriksen DP
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1409-1415. PubMed ID: 30136330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.
    Wechsler ME; Finn D; Gunawardena D; Westlake R; Barker A; Haranath SP; Pauwels RA; Kips JC; Drazen JM
    Chest; 2000 Mar; 117(3):708-13. PubMed ID: 10712995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?
    Sahiner UM; Arik Yilmaz E; Fontanella S; Haider S; Soyer O; Custovic A; Kalayci O; Sackesen C
    Int Arch Allergy Immunol; 2021; 182(12):1212-1221. PubMed ID: 34518469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Montelukast and neuropsychiatric events - a sequence symmetry analysis.
    Fox CW; Khaw CL; Gerke AK; Lund BC
    J Asthma; 2022 Dec; 59(12):2360-2366. PubMed ID: 34979844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What is the role of montelukast in asthma treatment?].
    Aksu K; Aksu F
    Tuberk Toraks; 2020 Sep; 68(3):328-330. PubMed ID: 33295731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of behavior-related adverse experiences in clinical trials of montelukast.
    Philip G; Hustad CM; Malice MP; Noonan G; Ezekowitz A; Reiss TF; Knorr B
    J Allergy Clin Immunol; 2009 Oct; 124(4):699-706.e8. PubMed ID: 19815116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In brief: Neuropsychiatric events with montelukast.
    Med Lett Drugs Ther; 2020 May; 62(1597):65. PubMed ID: 32555111
    [No Abstract]   [Full Text] [Related]  

  • 33. [Psychiatric disorders associated with montelukast: data from the National Pharmacovigilance Database].
    Marchand MS; Jonville-Béra AP; Autret-Leca E;
    Arch Pediatr; 2013 Mar; 20(3):269-73. PubMed ID: 23375423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients.
    Di Salvo E; Patella V; Casciaro M; Gangemi S
    Pulm Pharmacol Ther; 2020 Feb; 60():101875. PubMed ID: 31837440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should we use montelukast in wheezy children?
    Haq I; Harris C; Taylor J; McKean MC; Brodlie M
    Arch Dis Child; 2017 Nov; 102(11):997-998. PubMed ID: 28780506
    [No Abstract]   [Full Text] [Related]  

  • 36. Montelukast-induced adverse drug reactions: a review of case reports in the literature.
    Calapai G; Casciaro M; Miroddi M; Calapai F; Navarra M; Gangemi S
    Pharmacology; 2014; 94(1-2):60-70. PubMed ID: 25196099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and tolerability of intravenous montelukast in acute asthma exacerbations in Japanese patients.
    Adachi M; Taniguchi H; Tohda Y; Sano Y; Ishine T; Smugar SS; Hisada S
    J Asthma; 2012 Aug; 49(6):649-56. PubMed ID: 22742205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
    Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA
    Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing risk: Data from montelukast clinical trials.
    Kelsay K
    J Allergy Clin Immunol; 2009 Oct; 124(4):697-8. PubMed ID: 19815115
    [No Abstract]   [Full Text] [Related]  

  • 40. A Boxed Warning for Montelukast: The FDA Perspective.
    Clarridge K; Chin S; Eworuke E; Seymour S
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2638-2641. PubMed ID: 33744471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.